Golgi reassembly stacking protein 55 interacts with membrane-type (MT) 1-matrix metalloprotease (MMP) and furin and plays a role in the activation of the MT1-MMP zymogen

FEBS Journal

Volumn 277, Issue 15, 2010, Pages 3158-3175

  Roghi, Christian ^a,b   Jones, Louise ^b   Gratian, Matthew ^b   English, William R ^a,b   Murphy, Gillian ^a,b  

^a CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

furin; GRASP55; intracellular traffic; MT1 MMP; protease

Indexed keywords

ENZYME PRECURSOR; FURIN; GOLGI REASSEMBLY STACKING PROTEIN 55; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MATRIX PROTEIN; METALLOPROTEINASE; MT5 MMP; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GENE DISRUPTION; GENE OVEREXPRESSION; GOLGI COMPLEX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN MOTIF;

CELL LINE, TUMOR; CYTOPLASM; ENZYME ACTIVATION; ENZYME PRECURSORS; FURIN; HUMANS; MATRIX METALLOPROTEINASE 14; MEMBRANE PROTEINS; MULTIPROTEIN COMPLEXES;

EID: 77954717764     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07723.x     Document Type: Article

References (73)

1. Zucker S, Pei D, Cao J Lopez-Otin C (2003) Membrane type-matrix metalloproteinases (MT-MMP). Curr Top Dev Biol 54, 1 74.
2. Noël A, Gilles C, Bajou K, Devy L, Kebers F, Lewalle JM, Maquoi E, Munaut C, Remacle A Foidart JM (1997) Emerging roles for proteinases in cancer. Invasion Metastasis 17, 221 239.
3. Ellerbroek SM Stack MS (1999) Membrane associated matrix metalloproteinases in metastasis. Bioessays 21, 940 949.
4. Sato H, Takino T Miyamori H (2005) Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis. Cancer Sci 96, 212 217.
5. Itoh Y Seiki M (2006) MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 206, 1 8.
6. Will H, Atkinson SJ, Butler GS, Smith B Murphy G (1996) The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 271, 17119 17123.
7. Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM Murphy G (1996) Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 271, 17124 17131.
8. Holmbeck K, Bianco P, Yamada S Birkedal-Hansen H (2004) MT1-MMP: a tethered collagenase. J Cell Physiol 200, 11 19.
9. Seiki M (2003) Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett 194, 1 11.
10. Vihinen P Kahari VM (2002) Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 99, 157 166.
11. Genis L, Galvez BG, Gonzalo P Arroyo AG (2006) MT1-MMP: universal or particular player in angiogenesis? Cancer Metastasis Rev 25, 77 86.
12. Sabeh F, Ota I, Holmbeck K, Birkedal-Hansen H, Soloway P, Balbin M, Lopez-Otin C, Shapiro S, Inada M, Krane S et al. (2004) Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol 167, 769 781.
13. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW Weiss SJ (2003) Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114, 33 45.
14. Ueda J, Kajita M, Suenaga N, Fujii K Seiki M (2003) Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors. Oncogene 22, 8716 8722.
15. Gingras D Beliveau R (2009) Emerging concepts in the regulation of membrane-type 1 matrix metalloproteinase activity. Biochim Biophys Acta 1803, 142 150.
16. Gingras D, Bousquet-Gagnon N, Langlois S, Lachambre MP, Annabi B Beliveau R (2001) Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett 507, 231 236.
17. Lehti K, Valtanen H, Wickstrom SA, Lohi J Keski-Oja J (2000) Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J Biol Chem 275, 15006 15013.
18. Uekita T, Itoh Y, Yana I, Ohno H Seiki M (2001) Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J Cell Biol 155, 1345 1356.
19. Urena JM, Merlos-Suarez A, Baselga J Arribas J (1999) The cytoplasmic carboxy-terminal amino acid determines the subcellular localization of proTGF-(alpha) and membrane type matrix metalloprotease (MT1-MMP). J Cell Sci 112, 773 784.
20. Jiang A, Lehti K, Wang X, Weiss SJ, Keski-Oja J Pei D (2001) Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci USA 98, 13693 13698.
21. Rozanov DV, Ghebrehiwet B, Ratnikov B, Monosov EZ, Deryugina EI Strongin AY (2002) The cytoplasmic tail peptide sequence of membrane type-1 matrix metalloproteinase (MT1-MMP) directly binds to gC1qR, a compartment-specific chaperone-like regulatory protein. FEBS Lett 527, 51 57.
22. Remacle A, Murphy G Roghi C (2003) Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface. J Cell Sci 116, 3905 3916.
23. Wang X, Ma D, Keski-Oja J Pei D (2004) Co-recycling of MT1-MMP and MT3-MMP through the trans-Golgi network. Identification of DKV582 as a recycling signal. J Biol Chem 279, 9331 9336.
24. Nakahara H, Howard L, Thompson EW, Sato H, Seiki M, Yeh Y Chen WT (1997) Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci USA 94, 7959 7964.
25. Sounni NE, Devy L, Hajitou A, Frankenne F, Munaut C, Gilles C, Deroanne C, Thompson EW, Foidart JM Noel A (2002) MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J 16, 555 564.
26. D'Alessio S, Ferrari G, Cinnante K, Scheerer W, Galloway AC, Roses DF, Rozanov DV, Remacle AG, Oh ES, Shiryaev SA et al. (2008) Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism. J Biol Chem 283, 87 99.
27. Rozanov DV, Savinov AY, Williams R, Liu K, Golubkov VS, Krajewski S Strongin AY (2008) Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer. Cancer Res 68, 4086 4096.
28. Lehti K, Lohi J, Juntunen MM, Pei D Keski-Oja J (2002) Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase. J Biol Chem 277, 8440 8448.
29. Ludwig T, Theissen SM, Morton MJ Caplan MJ (2008) The cytoplasmic tail dileucine motif LL572 determines the glycosylation pattern of membrane-type 1 matrix metalloproteinase. J Biol Chem 283, 35410 35418.
30. Anilkumar N, Uekita T, Couchman JR, Nagase H, Seiki M Itoh Y (2005) Palmitoylation at Cys574 is essential for MT1-MMP to promote cell migration. FASEB J 19, 1326 1328.
31. Nyalendo C, Michaud M, Beaulieu E, Roghi C, Murphy G, Gingras D Beliveau R (2007) Src-dependent phosphorylation of membrane type I matrix metalloproteinase on cytoplasmic tyrosine 573: role in endothelial and tumour cell migration. J Biol Chem 282, 15690 15699.
32. Moss NMP, Wu YIP, Liu YM, Munshi HGM Stack MSP (2009) Modulation of the membrane type 1 matrix metalloproteinase cytoplasmic tail enhances tumor cell invasion and proliferation in three-dimensional collagen matrices. J Biol Chem 284, 19791 19799.
33. Uekita T, Gotoh I, Kinoshita T, Itoh Y, Sato H, Shiomi T, Okada Y Seiki M (2004) Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein-1 is a new member of the Cupin superfamily. A possible multifunctional protein acting as an invasion suppressor down-regulated in tumors. J Biol Chem 279, 12734 12743.
34. Labrecque L, Nyalendo C, Langlois S, Durocher Y, Roghi C, Murphy G, Gingras D Beliveau R (2004) Src-mediated tyrosine phosphorylation of caveolin-1 induces its association with membrane type 1 matrix metalloproteinase. J Biol Chem 279, 52132 52140.
35. Shorter J, Watson R, Giannakou ME, Clarke M, Warren G Barr FA (1999) GRASP55, a second mammalian GRASP protein involved in the stacking of Golgi cisternae in a cell-free system. EMBO J 18, 4949 4960.
36. Short B, Preisinger C, Korner R, Kopajtich R, Byron O Barr FA (2001) A GRASP55-rab2 effector complex linking Golgi structure to membrane traffic. J Cell Biol 155, 877 883.
37. Kuo A, Zhong C, Lane WS Derynck R (2000) Transmembrane transforming growth factor-alpha tethers to the PDZ domain-containing, Golgi membrane-associated protein p59/GRASP55. EMBO J 19, 6427 6439.
38. D'Angelo G, Prencipe L, Iodice L, Beznoussenko G, Savarese M, Marra P, Di Tullio G, Martire G, De Matteis MA Bonatti S (2009) GRASP65 and GRASP55 sequentially promote the transport of C-terminal valine-bearing cargos to and through the Golgi complex. J Biol Chem 284, 34849 34860.
39. Barr FA, Preisinger C, Kopajtich R Korner R (2001) Golgi matrix proteins interact with p24 cargo receptors and aid their efficient retention in the Golgi apparatus. J Cell Biol 155, 885 891.
40. Jesch SA, Lewis TS, Ahn NG Linstedt AD (2001) Mitotic phosphorylation of Golgi reassembly stacking protein 55 by mitogen-activated protein kinase ERK2. Mol Biol Cell 12, 1811 1817.
41. Barr FA, Puype M, Vandekerckhove J Warren G (1997) GRASP65, a protein involved in the stacking of Golgi cisternae. Cell 91, 253 262.
42. Yana I Weiss SJ (2000) Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol Biol Cell 11, 2387 2401.
43. Nakayama K (1997) Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 327, 625 635.
44. Remacle AG, Rozanov DV, Fugere M, Day R Strongin AY (2006) Furin regulates the intracellular activation and the uptake rate of cell surface-associated MT1-MMP. Oncogene 25, 5648 5655.
45. Wouters S, Leruth M, Decroly E, Vandenbranden M, Creemers JW, van de Loo JW, Ruysschaert JM Courtoy PJ (1998) Furin and proprotein convertase 7 (PC7)/lymphoma PC endogenously expressed in rat liver can be resolved into distinct post-Golgi compartments. Biochem J 336, 311 316.
46. Borg JP, Marchetto S, Le Bivic A, Ollendorff V, Jaulin-Bastard F, Saito H, Fournier E, Adelaide J, Margolis B Birnbaum D (2000) ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor. Nat Cell Biol 2, 407 414.
47. + channel Kir 2.3 to PSD-95 is regulated by protein kinase A phosphorylation. Neuron 17, 759 767.
48. Cao TT, Deacon HW, Reczek D, Bretscher A von Zastrow M (1999) A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor. Nature 401, 286 290.
49. Hegedus T, Sessler T, Scott R, Thelin W, Bakos E, Varadi A, Szabo K, Homolya L, Milgram SL Sarkadi B (2003) C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins. Biochem Biophys Res Commun 302, 454 461.
50. Birrane G, Chung J Ladias JA (2003) Novel mode of ligand recognition by the Erbin PDZ domain. J Biol Chem 278, 1399 1402.
51. Geijsen N, Uings IJ, Pals C, Armstrong J, McKinnon M, Raaijmakers JA, Lammers JW, Koenderman L Coffer PJ (2001) Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein. Science 293, 1136 1138.
52. Li AL, Li HY, Jin BF, Ye QN, Zhou T, Yu XD, Pan X, Man JH, He K, Yu M et al. (2004) A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis. J Biol Chem 279, 49251 49258.
53. Gimferrer I, Ibanez A, Farnos M, Sarrias MR, Fenutria R, Rosello S, Zimmermann P, David G, Vives J, Serra-Pages C et al. (2005) The lymphocyte receptor CD6 interacts with syntenin-1, a scaffolding protein containing PDZ domains. J Immunol 175, 1406 1414.
54. Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T Seiki M (2001) Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J 20, 4782 4793.
55. Srivastava S, Osten P, Vilim FS, Khatri L, Inman G, States B, Daly C, DeSouza S, Abagyan R, Valtschanoff JG et al. (1998) Novel anchorage of GluR2/3 to the postsynaptic density by the AMPA receptor-binding protein ABP. Neuron 21, 581 591.
56. Xu XZ, Choudhury A, Li X Montell C (1998) Coordination of an array of signaling proteins through homo- and heteromeric interactions between PDZ domains and target proteins. J Cell Biol 142, 545 555.
57. Hsueh YP, Kim E Sheng M (1997) Disulfide-linked head-to-head multimerization in the mechanism of ion channel clustering by PSD-95. Neuron 18, 803 814.
58. Wang Y, Seemann J, Pypaert M, Shorter J Warren G (2003) A direct role for GRASP65 as a mitotically regulated Golgi stacking factor. EMBO J 22, 3279 3290.
59. Lee AY, Akers KT, Collier M, Li L, Eisen AZ Seltzer JL (1997) Intracellular activation of gelatinase A (72-kDa type IV collagenase) by normal fibroblasts. Proc Natl Acad Sci USA 94, 4424 4429. (Pubitemid 27194257)
60. Deryugina EI, Ratnikov BI, Yu Q, Baciu PC, Rozanov DV Strongin AY (2004) Prointegrin maturation follows rapid trafficking and processing of MT1-MMP in furin-negative colon carcinoma LoVo cells. Traffic 5, 627 641.
61. Pei D Weiss SJ (1996) Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 271, 9135 9140.
62. Stawowy P, Meyborg H, Stibenz D, Borges Pereira Stawowy N, Roser M, Thanabalasingam U, Veinot JP, Chretien M, Seidah NG, Fleck E et al. (2005) Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis. Circulation 111, 2820 2827.
63. Kang T, Nagase H Pei D (2002) Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network. Cancer Res 62, 675 681.
64. Wang X Pei D (2001) Shedding of membrane type matrix metalloproteinase 5 by a furin-type convertase: a potential mechanism for down-regulation. J Biol Chem 276, 35953 35960.
65. Will H Hinzmann B (1995) cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 231, 602 608.
66. Wang P, Wang X Pei D (2004) Mint-3 regulates the retrieval of the internalized membrane-type matrix metalloproteinase, MT5-MMP, to the plasma membrane by binding to its carboxyl end motif EWV. J Biol Chem 279, 20461 20470.
67. Monea S, Jordan BA, Srivastava S, DeSouza S Ziff EB (2006) Membrane localization of membrane type 5 matrix metalloproteinase by AMPA receptor binding protein and cleavage of cadherins. J Neurosci 26, 2300 2312.
68. Srour N, Lebel A, McMahon S, Fournier I, Fugere M, Day R Dubois CM (2003) TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity. FEBS Lett 554, 275 283.
69. Atkinson SJ, Roghi C Murphy G (2006) MT1-MMP hemopexin domain exchange with MT4-MMP blocks enzyme maturation and trafficking to the plasma membrane in MCF7 cells. Biochem J 398, 15 22.
70. Schweizer A, Fransen JA, Bachi T, Ginsel L Hauri HP (1988) Identification, by a monoclonal antibody, of a 53-kD protein associated with a tubulo-vesicular compartment at the cis-side of the Golgi apparatus. J Cell Biol 107, 1643 1653.
71. Green DR, Banuls MP, Gearing AJH, Needham LA, White MRH Clements JM (1994) Generation of human umbilical vein endothelial cell lines which maintain their differentiated phenotype. Endothelium 2, 191 201.
72. Plaimauer B, Mohr G, Wernhart W, Himmelspach M, Dorner F Schlokat U (2001) 'Shed' furin: mapping of the cleavage determinants and identification of its C-terminus. Biochem J 354, 689 695.
73. Heussen C Dowdle EB (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102, 196 202.